Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Breast Cancer

  Free Subscription


23.03.2020

1 Am J Surg
3 Ann Oncol
4 Ann Surg Oncol
2 BMC Cancer
1 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
8 Breast Cancer Res Treat
3 Breast J
1 Cancer
1 Cancer Res
1 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
1 J Natl Cancer Inst
1 J Nucl Med
2 Lancet Oncol
1 Oncol Rep
1 Oncology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. CUI X, Zhu C, Chen P, Qu M, et al
    Effect of pectoral nerve block type II under general anesthesia on the immune function of patients with breast cancer.
    Am J Surg. 2020 Mar 8. pii: S0002-9610(20)30150.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. MURPHY N, Knuppel A, Papadimitriou N, Martin RM, et al
    Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with approximately 430 000 women.
    Ann Oncol. 2020 Mar 9. pii: S0923-7534(20)36019.
    PubMed     Text format     Abstract available

  3. ADAMS S, Dieras V, Barrios CH, Winer EP, et al
    Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer.
    Ann Oncol. 2020 Feb 20. pii: S0923-7534(20)36038.
    PubMed     Text format     Abstract available

  4. VAN DONGEN M, Kok M
    Mise en place: towards neoadjuvant chemo-immunotherapy for early triple-negative breast cancer.
    Ann Oncol. 2020 Mar 11. pii: S0923-7534(20)36075.
    PubMed     Text format    


    Ann Surg Oncol

  5. SMITH BL, Lanahan CR, Specht MC, Kelly BN, et al
    Correction to: Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
    Ann Surg Oncol. 2020 Mar 13. pii: 10.1245/s10434-020-08349.
    PubMed     Text format     Abstract available

  6. MUDGWAY R, Lum SS
    ASO Author Reflections: Improved Survival for Stage IV Breast Cancer: Considerations for Surgery in the Era of HER2-Targeted Therapy.
    Ann Surg Oncol. 2020 Mar 13. pii: 10.1245/s10434-020-08347.
    PubMed     Text format    

  7. SMITH BL, Kelly BN, Gadd MA
    ASO Author Reflections: Image-Guided Margin Assessment for Breast Cancer.
    Ann Surg Oncol. 2020 Mar 16. pii: 10.1245/s10434-020-08332.
    PubMed     Text format    

  8. ZHELEVA V, Nelson RA, Dumitra S, Vora NL, et al
    Time to Adjuvant Radiotherapy in Breast Cancer Affects Survival: Implications for the American College of Surgeons Commission on Cancer Quality Metrics.
    Ann Surg Oncol. 2020 Mar 17. pii: 10.1245/s10434-020-08326.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. CAPUTO R, Cazzaniga ME, Sbrana A, Torrisi R, et al
    Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study.
    BMC Cancer. 2020;20:232.
    PubMed     Text format     Abstract available

  10. SAN MIGUEL Y, Gomez SL, Murphy JD, Schwab RB, et al
    Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status.
    BMC Cancer. 2020;20:228.
    PubMed     Text format     Abstract available


    Breast Cancer

  11. SOLIS-CASTILLO LA, Garcia-Romo GS, Diaz-Rodriguez A, Reyes-Hernandez D, et al
    Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
    Breast Cancer. 2020 Mar 16. pii: 10.1007/s12282-020-01079.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  12. WEN S, Manuel L, Doolan M, Westhuyzen J, et al
    Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients.
    Breast Cancer (Dove Med Press). 2020;12:27-35.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  13. QIU SQ, van Rooijen J, Nienhuis HH, van der Vegt B, et al
    High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.
    Breast Cancer Res. 2020;22:30.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  14. PANZIRONI G, Moffa G, Galati F, Marzocca F, et al
    Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner.
    Breast Cancer Res Treat. 2020 Mar 17. pii: 10.1007/s10549-020-05592.
    PubMed     Text format     Abstract available

  15. HASSETT MJ, Li H, Burstein HJ, Punglia RS, et al
    Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes.
    Breast Cancer Res Treat. 2020 Mar 17. pii: 10.1007/s10549-020-05587.
    PubMed     Text format     Abstract available

  16. SIMONS JM, Koppert LB, Luiten EJT, van der Pol CC, et al
    De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
    Breast Cancer Res Treat. 2020 Mar 16. pii: 10.1007/s10549-020-05589.
    PubMed     Text format     Abstract available

  17. GONZALEZ TL, Hancock M, Sun S, Gersch CL, et al
    Correction to: Targeted degradation of activating estrogen receptor alpha ligand-binding domain mutations in human breast cancer.
    Breast Cancer Res Treat. 2020 Mar 16. pii: 10.1007/s10549-020-05594.
    PubMed     Text format     Abstract available

  18. MA G, Zhang B, Xu J
    Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
    Breast Cancer Res Treat. 2020 Mar 14. pii: 10.1007/s10549-020-05593.
    PubMed     Text format    

  19. CROLLEY VE, Marashi H, Rawther S, Sirohi B, et al
    The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
    Breast Cancer Res Treat. 2020 Mar 13. pii: 10.1007/s10549-020-05578.
    PubMed     Text format     Abstract available

  20. ISHIGURO H, Masuda N, Sato N, Higaki K, et al
    A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.
    Breast Cancer Res Treat. 2020 Mar 13. pii: 10.1007/s10549-020-05590.
    PubMed     Text format     Abstract available

  21. YUAN C, Xie Z, Bian J, Huo J, et al
    Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis.
    Breast Cancer Res Treat. 2020 Mar 14. pii: 10.1007/s10549-020-05591.
    PubMed     Text format     Abstract available


    Breast J

  22. LOMBARDI A, Vitale V, Nigri G, Olivieri C, et al
    Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
    Breast J. 2020 Mar 16. doi: 10.1111/tbj.13807.
    PubMed     Text format     Abstract available

  23. LOHANI KR, Kumar C, Kataria K, Srivastava A, et al
    Role of tranexamic acid in axillary lymph node dissection in breast cancer patients.
    Breast J. 2020 Mar 15. doi: 10.1111/tbj.13810.
    PubMed     Text format     Abstract available

  24. DOSTALEK L, Lednicky S, Saskova P, Steyerova P, et al
    Is it possible to abandon sentinel lymph node biopsy in breast cancer patients with negative axillary ultrasound in the post-Z0011 era? A retrospective analysis.
    Breast J. 2020 Mar 18. doi: 10.1111/tbj.13814.
    PubMed     Text format    


    Cancer

  25. SHARIFF-MARCO S, Gomez SL, Canchola AJ, Fullington H, et al
    Nativity, ethnic enclave residence, and breast cancer survival among Latinas: Variations between California and Texas.
    Cancer. 2020 Mar 17. doi: 10.1002/cncr.32845.
    PubMed     Text format     Abstract available


    Cancer Res

  26. MAJORINI MT, Cancila V, Rigoni A, Botti L, et al
    Infiltrating mast cell-mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype.
    Cancer Res. 2020 Mar 16. pii: 0008-5472.CAN-19-3596.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  27. SAUDER CAM, Bateni SB, Davidson AJ, Nishijima DK, et al
    Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review.
    Clin Breast Cancer. 2019 Dec 19. pii: S1526-8209(19)30763.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  28. PARSONS HA, Rhoades J, Reed SC, Gydush G, et al
    Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer.
    Clin Cancer Res. 2020 Mar 13. pii: 1078-0432.CCR-19-3005.
    PubMed     Text format     Abstract available


    Eur J Cancer

  29. WERUTSKY G, Untch M, Hanusch C, Fasching PA, et al
    Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials.
    Eur J Cancer. 2020;130:92-101.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  30. JEZEQUEL P, Patsouris A, Guette C, Juin PP, et al
    RE: Immune checkpoint profiles in luminal B breast cancer (Alliance).
    J Natl Cancer Inst. 2020 Mar 19. pii: 5810085. doi: 10.1093.
    PubMed     Text format    


    J Nucl Med

  31. ROUSSEAU C, Goldenberg DM, Colombie M, Sebille JC, et al
    Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.236000. doi: 10.2967/jnumed.119.236000.
    PubMed     Text format     Abstract available


    Lancet Oncol

  32. SWAIN SM, Miles D, Kim SB, Im YH, et al
    Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
    Lancet Oncol. 2020 Mar 12. pii: S1470-2045(19)30863.
    PubMed     Text format     Abstract available

  33. LAMBERTINI M, Vaz-Luis I
    Is HER2-positive metastatic breast cancer still an incurable disease?
    Lancet Oncol. 2020 Mar 12. pii: S1470-2045(20)30058.
    PubMed     Text format    


    Oncol Rep

  34. HAN R, Zhao J, Lu L
    MicroRNA34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.
    Oncol Rep. 2020 Mar 18. doi: 10.3892/or.2020.7549.
    PubMed     Text format     Abstract available


    Oncology

  35. THARAKAN S, Zimmerman B, Ru M, Blanter J, et al
    Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
    Oncology. 2020 Mar 17:1-4. doi: 10.1159/000506076.
    PubMed     Text format     Abstract available


    PLoS One

  36. KIM YS, Sun S, Yoon JS, Ko YH, et al
    Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    PLoS One. 2020;15:e0230261.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: